http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6558660-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7449ca99fbf1c556219fe28876cbf2a9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-206
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2001-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40df388f35d7ef10681d2d7b14d8cde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aa4cc79c51dfd56ddef9ca5a9395a94
publicationDate 2003-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6558660-B2
titleOfInvention Method for regulating IL-10 with IL-9, and applications thereof
abstract The invention involves the recognition of IL-9 as a molecule involved in induction of IL-10. Administration of IL-9 leads to protection against conditions where IL-10 production is warranted, such as infections by Gram negative bacteria. Examples of such conditions are septic shock and endotoxemia. Also a part of the invention are methods of treatment where IL-9 and a phosphodiesterase inhibitor are administered to a subject. Compositions, such as kits which include these two components are a part of the invention, as is treatment of conditions involving excess IL-10 production by administering an IL-9 inhibitor.
priorityDate 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127866646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127735754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127586751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401720

Total number of triples: 31.